Vinpai S.A. ALVIN
EURONEXT · France · Health Technology
€2.40-0.10 (-4.00%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
SAINT-DOLAY, France, October 01, 2026--Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker symbol: ALVIN), a specialist in the design, manufacture, and marketing of functional ingredients derived from algae and plants for the food and cosmetics industries ("Vinpai" or the "Company"), today announces its results for the first half of 2026, ended June 30, 2026, as approved by the Board of Directors today.
SAINT-DOLAY, France, July 16, 2026--Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker symbol: ALVIN), a specialist in the design, manufacture, and marketing of functional ingredients derived from algae and plants for the food and cosmetics industries, today announced its revenue for the first half of the fiscal year, ended June 30, 2026.
MUMBAI, India, July 08, 2026--Regulatory News: This press release must not be published, distributed or transmitted, directly or indirectly, in the United States of America, Australia, Canada, South Africa or Japan.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.